Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.

Clapper ML, Gary MA, Coudry RA, Litwin S, Chang WC, Devarajan K, Lubet RA, Cooper HS.

Inflamm Bowel Dis. 2008 Oct;14(10):1341-7. doi: 10.1002/ibd.20489.

PMID:
18452197
2.
3.

Differential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic amines.

Chang WC, Zenser TV, Cooper HS, Clapper ML.

Cancer Lett. 2013 Jun 28;334(1):62-8. doi: 10.1016/j.canlet.2013.02.013. Epub 2013 Feb 13. Review.

4.

Oral 5-ASA therapy in ulcerative colitis: what are the implications of the new formulations?

Sandborn WJ.

J Clin Gastroenterol. 2008 Apr;42(4):338-44. doi: 10.1097/MCG.0b013e3181595b56. Review.

PMID:
18277908
5.

[Experimental colitis induced by dextran sulfate].

Umene Y, Makiyama K, Hara K.

Ryoikibetsu Shokogun Shirizu. 1994;(6):29-31. Review. Japanese. No abstract available.

PMID:
7736047
6.

Optimizing therapy in patients with pancolitis.

Cuffari C, Present DH, Bayless TM, Lichtenstein GR.

Inflamm Bowel Dis. 2005 Oct;11(10):937-46. Review.

PMID:
16189424

Supplemental Content

Support Center